Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study

Efficacy and safety of trastuzumab emtansine treatment in patients with metastatic HER-2 positive breast cancer: a single center study

Introduction: Trastuzumab emtansine (T-DM1) is one of the effective treatment options in human epidermal growth factor receptor 2 (HER2) positive breast cancer patients. In this study, we aimed to find the effect of T-DM1 on survival, its tolerability and prognostic factors of T-DM1 treatment. Mate...

Full description

Bibliographic Details
Main Authors: Eyyup Cavdar, Kubilay Karaboyun, Yakup Iriagac, Okan Avci, Erdoğan Selcuk Seber
Format: Article
Language:English
Published: Emergency Department of Hospital San Pedro (Logroño, Spain) 2022-08-01
Series:Iberoamerican Journal of Medicine
Subjects:
metastatic breast cancer
trastuzumab emtansine
survival
adverse events
Online Access:https://www.iberoamjmed.com/article/doi/10.53986/ibjm.2022.0033

Similar Items

Similar Items